Aripiprazole versus ziprasidone for schizophrenia

Hong Ling Yang*, Jiangang Zheng, Bin Li, Sai Zhao, Wei Zheng

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review


This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

Original languageEnglish
Article numberCD012811
Number of pages13
JournalCochrane Database of Systematic Reviews
Issue number9
Publication statusPublished - 28 Sept 2017

Scopus Subject Areas

  • Pharmacology (medical)


Dive into the research topics of 'Aripiprazole versus ziprasidone for schizophrenia'. Together they form a unique fingerprint.

Cite this